Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 5:46 pm Purchase | 13G | Dyne Therapeutics Inc. DYN | RA CAPITAL MANAGEMENT L.P. | 6,381,144 6.400% | 1,167,483 (+22.39%) | View |
| 2024-11-14 4:32 pm Sale | 13G | Dyne Therapeutics Inc. DYN | Atlas Venture Fund XI L.P. | 5,714,057 5.700% | -1,628,026 (-22.17%) | View |
| 2024-11-14 4:23 pm Sale | 13G | Dyne Therapeutics Inc. DYN | CITADEL ADVISORS LLC | 2,960,081 3.000% | -112,506 (-3.66%) | View |
| 2024-11-14 10:28 am Purchase | 13G | Dyne Therapeutics Inc. DYN | JANUS HENDERSON GROUP PLC JHG | 6,813,163 6.800% | 6,813,163 (New Position) | View |
| 2024-11-14 09:27 am Purchase | 13G | Dyne Therapeutics Inc. DYN | Deep Track Capital LP | 3,282,000 3.270% | 1,282,000 (+64.10%) | View |
| 2024-11-14 07:00 am Sale | 13G | Dyne Therapeutics Inc. DYN | Forbion Capital Fund IV Cooperatief U.A. | 5,795,364 5.800% | -335,715 (-5.48%) | View |
| 2024-11-14 06:34 am Purchase | 13G | Dyne Therapeutics Inc. DYN | RTW INVESTMENTS LP | 6,818,641 6.800% | 6,818,641 (New Position) | View |
| 2024-11-12 2:20 pm Unchanged | 13G | Dyne Therapeutics Inc. DYN | VANGUARD GROUP INC | 6,864,137 6.830% | 0 (Unchanged) | View |
| 2024-11-12 09:55 am Purchase | 13G | Dyne Therapeutics Inc. DYN | FMR LLC | 9,026,697 8.990% | 9,026,697 (New Position) | View |
| 2024-11-08 5:31 pm Unchanged | 13G | Dyne Therapeutics Inc. DYN | BlackRock Inc. BLK | 7,794,217 7.800% | 0 (Unchanged) | View |
| 2024-11-04 10:20 am Purchase | 13G | Dyne Therapeutics Inc. DYN | VANGUARD GROUP INC | 6,864,137 6.830% | 6,864,137 (New Position) | View |
| 2024-10-22 3:24 pm Purchase | 13G | Dyne Therapeutics Inc. DYN | BlackRock Inc. BLK | 7,794,217 7.800% | 4,005,535 (+105.72%) | View |
| 2024-04-04 7:04 pm Purchase | 13G | Dyne Therapeutics Inc. DYN | RA CAPITAL MANAGEMENT L.P. | 5,213,661 6.400% | 5,213,661 (New Position) | View |
| 2024-02-14 4:57 pm Purchase | 13G | Dyne Therapeutics Inc. DYN | CITADEL ADVISORS LLC | 3,072,587 5.000% | 91,263 (+3.06%) | View |
| 2024-02-14 08:39 am Sale | 13G | Dyne Therapeutics Inc. DYN | Deep Track Capital LP | 2,000,000 3.260% | -2,500,000 (-55.56%) | View |
| 2024-02-12 4:06 pm Sale | 13G | Dyne Therapeutics Inc. DYN | MPM BIOVENTURES 2018 L.P. | 3,451,303 4.300% | -1,519,596 (-30.57%) | View |
| 2024-02-09 4:09 pm Purchase | 13G | Dyne Therapeutics Inc. DYN | Atlas Venture Fund XI L.P. | 7,342,083 9.100% | 15,966 (+0.22%) | View |
| 2024-01-29 3:26 pm Purchase | 13G | Dyne Therapeutics Inc. DYN | BlackRock Inc. BLK | 3,788,682 6.200% | 1,195,158 (+46.08%) | View |
| 2024-01-19 4:38 pm Purchase | 13G | Dyne Therapeutics Inc. DYN | Deep Track Capital LP | 4,500,000 5.550% | 2,500,000 (+125.00%) | View |
| 2024-01-19 09:08 am Sale | 13G | Dyne Therapeutics Inc. DYN | Deep Track Capital LP | 2,000,000 3.260% | -684,200 (-25.49%) | View |